In the past decade, an exciting realization has been that diverse liver diseases—ranging
from nonalcoholic steatohepatitis, alcoholic steatohepatitis and cirrhosis to hepatocellular …

The largest surface of the human body exposed to the external environment is the gut. At this
level, the intestinal barrier includes luminal microbes, the mucin layer, gastrointestinal …

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide and
parallels comorbidities such as obesity, metabolic syndrome, dyslipidemia, and diabetes …

Nonalcoholic fatty liver disease (NAFLD) is leading chronic liver syndrome worldwide. Gut
microbiota dysbiosis significantly contributes to the pathogenesis and severity of NAFLD …

Aim Schisandra chinensis is a well-known traditional Chinese medicine used mainly as a
recipe for hepatoprotection. Modern researches have revealed that the hepatoprotection is …

Genipin is an aglycone derived from the geniposide, the most abundant iridoid glucoside
constituent of Gardenia jasminoides Ellis. For decades, genipin is the focus of studies as a …

Oxidative stress is known to be an inseparable factor involved in the presentation of liver
disorders. Free radicals interfere with DNA, proteins, and lipids, which are crucial in liver …

Acute pancreatitis (AP) is one of the most common acute abdominal conditions, and its
incidence has been increasing for years. Approximately 15–20% of patients develop severe …

The term, gut–liver axis, is used to highlight the close anatomical and functional relationship
between the intestine and the liver. It has been increasingly recognized that the gut–liver …

Targeted therapy is an emerging treatment strategy for alcoholic liver disease (ALD).
Inflammation plays an important role in the occurrence and development of ALD, and is a …